Advent Life Sciences Announces Close of Two New Funds Totalling $215 million to Translate Early-Stage Research into Impactful Medicines for Patients ...Middle East

PR Newswire - News
Advent Life Sciences Announces Close of Two New Funds Totalling $215 million to Translate Early-Stage Research into Impactful Medicines for Patients
LONDON, Feb. 18, 2021 /PRNewswire/ -- Advent Life Sciences, a leading transatlantic venture investor focused on building innovative life science companies in the UK, Europe and the US, announced today that it has closed two new funds with commitments totalling $215 million. Advent Life...

Hence then, the article about advent life sciences announces close of two new funds totalling 215 million to translate early stage research into impactful medicines for patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Advent Life Sciences Announces Close of Two New Funds Totalling $215 million to Translate Early-Stage Research into Impactful Medicines for Patients )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News